Spread the Word 📣

Help this story reach more people by sharing it with your social network.

Choose a platform, pick a pre-written post, customize it if you'd like, and click Share.

Paradigm Therapeutics, Inc. is excited to share our latest milestone, and we’re proud of the teams and partners who helped make this happen! 🎉 “Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA "Best Start-Up" Award SD-101 (Zorblesia™) is the First Topical Therapy Developed to Treat Wounds and Lesions Across the Entire Skin Surface of All Epidermolysis Bullosa (EB) Subtypes” Check out the announcement and join the conversation: #Paradigm Therapeutics, Inc.

Press Release from PR Newswire www.prnewswire.com

Select social network:

Platforms